We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress
Sign In
Advertise with Us
BIO-RAD LABORATORIES

EKF Diagnostics

Manufactures analysers for the measurement of glucose, lactate, hemoglobin, hematocrit and HbA1c for GP surgeries, ph... read more Featured Products: More products

Download Mobile App





EKF Highlights Diagnostic Technologies for Point-of-Care Testing Applications

By LabMedica International staff writers
Posted on 13 Nov 2023
Print article
Image: EKF is showcasing its products and services at MEDICA 2023 at Hall 3, Stand B69 (Photo courtesy of EKF Diagnostics)
Image: EKF is showcasing its products and services at MEDICA 2023 at Hall 3, Stand B69 (Photo courtesy of EKF Diagnostics)

EKF Diagnostics (Cardiff, Wales, UK) is showcasing its diagnostic technologies and biotechnology solutions at MEDICA 2023 that empower healthcare and medical providers to make informed clinical decisions through point-of-care testing and life sciences applications.

EKF offers cutting-edge point-of-care diagnostic solutions that provide healthcare professionals and patients with rapid, accurate, and accessible testing capabilities and results. The company’s technologies allow for informed decision-making, timely interventions, and improved patient outcomes at the point of care. EKF leads in supporting life sciences applications and research through innovative biotechnology solutions. The company’s comprehensive portfolio offers powerful tools to researchers, scientists, and clinicians for accurate and reliable delivery and results, driving breakthrough discoveries and advancements in healthcare and medical understanding.

Visitors to the EKF booth can explore the company’s range of point-of-care medical diagnostic solutions for hematology and diabetes, including the DiaSpect Tm and Hemo Control hemoglobin analyzers, the Biosen C-Line glucose and lactate analyzer, and the Quo-Test and Quo-Lab HbA1c Analyzers. They can also discover more about EKF Link, the company’s optional software platform designed to provide a flexible and secure method for connecting point-of-care devices to hospital and laboratory IT systems. Additionally, visitors can learn more about EKF Life Sciences, and the company’s latest developments in microbial fermentation, custom bioprocessing, and contract manufacturing.

EKF’s DiaSpect Tm is a hand-held analyzer that provides immediate hemoglobin results and hematocrit calculation while the Hemo Control hemoglobin analyzer delivers accurate hemoglobin and hematocrit results with one simple test. Similarly, the Biosen C-Line Line glucose and lactate analyzer from EKF is designed for lab-accurate glucose and lactate measurement in one test. Among other products on display at MEDICA 2023 is the revolutionary Quo-Lab semi-automated analyzer for HbA1c measurement that provides affordable A1c testing with results in just four minutes. The Quo-Test fully automated analyzer on display at MEDICA 2023 is designed for fast, accurate, and reliable HbA1c measurement with results available in only four minutes.

Related Links:
EKF Diagnostics 

Platinum Supplier
Xylazine Immunoassay Test
Xylazine ELISA
New
Gold Supplier
Spinal Fluid Cell Count Control
Spinalscopics
Complement 3 (C3) Test
GPP-100 C3 Kit
New
H. pylori Test
QuickVue H. pylori Test

Print article

Channels

Clinical Chemistry

view channel
Image: A module with eight micro-devices, complete with microfluidic channels and drive motors (Photo courtesy of U.S Department of Energy)

Highly Sensitive pH Sensor to Aid Detection of Cancers and Vector-Borne Viruses

Understanding the acidity or alkalinity of substances through pH measurement is crucial in many fields, from environmental monitoring to healthcare product safety. In many cases, these measurements must... Read more

Molecular Diagnostics

view channel
Image: The PrismRA blood test helps target best treatments for patients with rheumatoid arthritis (Photo courtesy of Scipher Medicine)

Groundbreaking Rheumatoid Arthritis Blood Test Predicts Treatment Response

Rheumatoid arthritis (RA), an autoimmune disease affecting joints and other systems in the body, impacts millions globally. Typically, the initial biologic treatment involves anti-inflammatory drugs from... Read more

Hematology

view channel
Image: The QScout hematology analyzer has received US FDA 510(k) clearance (Photo courtesy of Ad Astra Diagnostics)

First Rapid-Result Hematology Analyzer Reports Measures of Infection and Severity at POC

Sepsis, a critical medical condition that arises as an extreme response to infection, poses a significant health threat. It occurs when an infection triggers a widespread inflammatory response in the body.... Read more

Immunology

view channel
Image: PointCheck is the world’s first device for non-invasive white cell monitoring (Photo courtesy of Leuko Labs)

World’s First Portable, Non-Invasive WBC Monitoring Device to Eliminate Need for Blood Draw

One of the toughest challenges for cancer patients undergoing chemotherapy is experiencing a low count of white blood cells, also known as neutropenia. These cells play a crucial role in warding off infections.... Read more

Microbiology

view channel
Image: Current testing methods for antibiotic susceptibility rely on growing bacterial colonies in the presence of antibiotics (Photo courtesy of 123RF)

Rapid Antimicrobial Susceptibility Test Returns Results within 30 Minutes

In 2019, antimicrobial resistance (AMR) was responsible for the deaths of approximately 1.3 million individuals. The conventional approach for testing antimicrobial susceptibility involves cultivating... Read more

Pathology

view channel
Image: AI methods used in satellite imaging can help researchers analyze tumor images (Photo courtesy of Karolinska Institutet)

AI Approach Combines Satellite Imaging and Ecology Techniques for Analysis of Tumor Tissue

Advancements in tumor imaging technology have significantly enhanced our ability to observe the minute details of tumors, but this also brings the challenge of interpreting vast amounts of data generated... Read more

Industry

view channel
Image: The acquisition significantly expands Medix Biochemica’s portfolio of IVD raw materials (Photo courtesy of ViroStat)

Medix Biochemica Acquires US-Based ViroStat to Expand Infectious Diseases Antibody Offering

Medix Biochemica (Espoo, Finland), a supplier of critical raw materials to the in vitro diagnostics (IVD) industry, has acquired ViroStat LLC (Portland, ME, USA), a provider of infectious disease antibodies... Read more
Copyright © 2000-2023 Globetech Media. All rights reserved.